semaglutide news oct 26 2025 today october Half of people stop taking popular weight-loss drug within a year, study finds semaglutide news october 2025 – 🚨 Top-Line Results: Mazdutide vs.

Orforglipron is different because its the first daily pill , giving patients a needle-free option

On this basis, most experts (and therefore, we) err on the side of caution

Heart failure Dapagliflozin and empagliflozin are indicated for the treatment of symptomatic chronic heart failure regardless of ejection fraction in adults with or without type 2 diabetes

Employer coverage is rapidly expanding - 44% of large employers now cover GLP-1s for obesity, with 21% more considering coverage within three years

If you have been wondering how to get prescribed Ozempic for weight loss, there are many hoops to jump through before you can begin treatment

Clinical trials have shown that Tirzepatide leads to greater HbA1c and body weight reductions compared to semaglutide